<DOC>
	<DOC>NCT02190175</DOC>
	<brief_summary>This is a multicentre non interventional observational study with the objective to follow up patients with atrial fibrillation who based on current indications are treated with per os flecainide , for cardiac pulse maintenance.</brief_summary>
	<brief_title>Management of Atrial Fibrillation With Flecainide : the AFFLEC Study</brief_title>
	<detailed_description>the study objectives are - record safety and efficiency of flecainide as antiarrythmic treatment in atrial fibrillation - study of flecainide in ST interval</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Flecainide</mesh_term>
	<criteria>patients with history of atrial fibrillation patients able to give informed consent patients with coronary disease or other cardiopathy with left heart champer affected</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>